Johnson & Johnson Launches ETHICON™ 4000 Stapler with World’s First 3D Stapling Technology in Asia, Debuts in China

China Finance and Economics News, November 6th: Today, Johnson & Johnson Medical Technology announced at the eighth CIIE that its subsidiary ETHICON^™4000, as the first 3D stapler endoscopic surgical device from Johnson & Johnson, makes its debut in Asia and will initially serve patients in China.

As a new milestone in the development of endoscopic stapler technology over the past thirty years, ETHICON^™4000 groundbreaking breakthrough in traditional B-type planar stapling technology, leading the new era of 3D立体成钉.

In surgical procedures, the integrity of anastomosed tissues is crucial for postoperative recovery and the prevention of complications. With the continuous advancement of medical technology and the increasing use of combination therapies, the condition of patients' tissues has become increasingly complex. Factors such as uneven tissue thickness and fragile texture may prevent the stapler from securely fastening the tissue, potentially leading to blood leakage and increasing intraoperative risks. Furthermore, if the staples fail to fully close, these "malformed staples" can become potential sites for tissue leakage, raising the likelihood of infection, secondary surgeries, or prolonged hospital stays. This not only increases the physical, mental, and financial burden on patients but also places additional strain on healthcare system resources.

　　ETHICON^™The 4000-laparoscopic stapler exclusively features Johnson & Johnson's world-first 3D structural staple cartridge, achieving a structural breakthrough from two-dimensional to three-dimensional. Compared with the traditional B-shaped planar staple technology, the 3D structure allows the staples to fully adhere to the tissue at more comprehensive angles, enhancing the integrity of the anastomosis and thereby reducing blood leakage caused by incomplete suturing. Data shows that the 3D structural staple system can reduce the incidence of interventions on the suture line due to bleeding by 23%. Combined with innovative preloaded chip technology, ETHICON^™The 4000-laparoscopic stapler can sense the tissue status in real time and dynamically adjust the stapling process based on key parameters such as tissue thickness to enhance the 3D staple formation, which helps reduce postoperative complications and improve patient outcomes.

　　“ETHICON^™"4000 is a milestone marking a leapfrog breakthrough in endoscopic stapler technology. Each tiny 3D立体吻合钉 it carries embodies the immense power of technological innovation, reflecting our unwavering pursuit of excellence and our steadfast determination to profoundly impact patient health." said Oliwen, General Manager of the Surgical Division at Johnson & Johnson Medical Technology China. This time, ETHICON^™As the first launch in Asia, 4000 is now able to serve patients in China ahead of schedule. This not only marks a new era for surgical stapler technology but also represents Johnson & Johnson’s firm commitment to advancing healthcare and supporting the construction of "Healthy China."